Similarly, the level of LIMA1 in serum sEV of MASH patients was higher than in healthy controls (Figure 1M), with a diagnostic efficiency of 0.86 (Figure 1N), showing better performance than the current diagnostic indicator Fib‐4 (Figure 1N). Here, LIMA1 is linked to metabolic dysfunction-associated steatohepatitis.